Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization

The Role of Formylated Peptides and Formyl Peptide Receptor 1 in Governing Neutrophil Function during Acute Inflammation

(2015) David A. Dorward et al.   AMERICAN JOURNAL OF PATHOLOGY

Cyclization of the Urokinase Receptor-Derived Ser-Arg-Ser-Arg-Tyr Peptide Generates a Potent Inhibitor of Trans-Endothelial Migration of Monocytes

(2015) Ali Munaim Yousif et al.   PLoS One

The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation

(2014) Marco Genua et al.   GUT

Disequilibrium of M1 and M2 Macrophages Correlates with the Development of Experimental Inflammatory Bowel Diseases

(2014) Wei Zhu et al.   IMMUNOLOGICAL INVESTIGATIONS

The microbiome revolution

(2014) Martin J. Blaser   JOURNAL OF CLINICAL INVESTIGATION

Cross-Desensitization of CCR1, but Not CCR2, following Activation of the Formyl Peptide Receptor FPR1

(2014) F. Bednar et al.   JOURNAL OF IMMUNOLOGY

A Review on Chemical-Induced Inflammatory Bowel Disease Models in Rodents

(2014) Puneet Kaur Randhawa et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors

(2014) Dominik Alexander Bloes et al.   NATURE REVIEWS MICROBIOLOGY

Ectoenzymes controlling leukocyte traffic

(2012) Marko Salmi et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma

(2012) Mingyong Liu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Regulation of the Formyl Peptide Receptor 1 (FPR1) Gene in Primary Human Macrophages

(2012) Claudio Gemperle et al.   PLoS One

The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling

(2011) Maria Vincenza Carriero et al.   CURRENT PHARMACEUTICAL DESIGN

Intestinal Bacteria and the Regulation of Immune Cell Homeostasis

(2010) David A. Hill et al.   Annual Review of Immunology

The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor

(2010) Nunzia Montuori et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

The soluble form of urokinase receptor promotes angiogenesis through its Ser88-Arg-Ser-Arg-Tyr92 chemotactic sequence

(2010) K. BIFULCO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Revisiting Crohn's disease as a primary immunodeficiency of macrophages: Figure 1.

(2009) Jean-Laurent Casanova et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Synergistic Induction of Inflammation by Bacterial Products Lipopolysaccharide and fMLP: An Important Microbial Pathogenic Mechanism

(2009) L.-Y. Chen et al.   JOURNAL OF IMMUNOLOGY

Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis

(2009) M. V. Carriero et al.   MOLECULAR CANCER THERAPEUTICS

An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor

(2008) Katia Bifulco et al.   FEBS LETTERS

Moving targets: cell migration inhibitors as new anti-inflammatory therapies

(2008) Charles R Mackay   NATURE IMMUNOLOGY